Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

EHA 2020 | Venetoclax in R/R MM patients

Nina Shah • 8 Jun 2020
EHA 2020
Multiple Myeloma Venetoclax
BELLINI

Nina Shah, MD, of the University of California, San Francisco, CA, outlines the use of venetoclax in relapsed/refractory (R/R) multiple myeloma patients, highlighting the BELLINI trial (NCT02755597). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nina Shah

Representation of women in hematology and oncology
2:07
Representation of women in hematology and oncology
Nina Shah • 15 Jun 2024
T-Cell Engagers: targets, challenges and opportunity
19:39
T-Cell Engagers: targets, challenges and opportunity
Nina Shah • 27 Mar 2022
NKTR-255 in multiple myeloma and NHL
1:28
NKTR-255 in multiple myeloma and NHL
Nina Shah • 10 Dec 2021
Reporting patient experiences during the KarMMa trial
2:15
Reporting patient experiences during the KarMMa trial
Nina Shah • 10 Dec 2021

Related Videos

Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
4:32
Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
Nina Shah • 18 Dec 2025
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
3:36
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
Nina Shah • 7 Dec 2025
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Nina Shah • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Nina Shah • 15 Dec 2025
The content of VJHemOnc is intended for healthcare professionals